Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali

Background. In 2010, mass vaccination with a then-new meningococcal A polysaccharide–tetanus toxoid protein conjugate vaccine (PsA-TT, or MenAfriVac) was undertaken in 1- to 29-year-olds in Bamako, Mali. Whether vaccination with PsA-TT effectively boosts tetanus immunity in a population with heterog...

Descripción completa

Detalles Bibliográficos
Autores principales: Basta, Nicole E., Borrow, Ray, Berthe, Abdoulaye, Onwuchekwa, Uma, Dembélé, Awa Traoré Eps, Almond, Rachael, Frankland, Sarah, Patel, Sima, Wood, Daniel, Nascimento, Maria, Manigart, Olivier, Trotter, Caroline L., Greenwood, Brian, Sow, Samba O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639490/
https://www.ncbi.nlm.nih.gov/pubmed/26553691
http://dx.doi.org/10.1093/cid/civ513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639490/
https://www.ncbi.nlm.nih.gov/pubmed/26553691
http://dx.doi.org/10.1093/cid/civ513

Ejemplares similares